
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW130288 |
Basil Drug MetabolismHomo sapiens
|
Creator: Selena Created On: September 14, 2023 at 21:15 Last Updated: September 14, 2023 at 21:15 |
PW064772 |
signaling
Basic mechanism of action of PPARa, PPARb(d) and PPARg and effects on gene expressionHomo sapiens
Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined.
|
Creator: Aidin Foroutannaddafi Created On: June 19, 2018 at 14:57 Last Updated: June 19, 2018 at 14:57 |
PW130850 |
Basic Fibroblast Growth Factor Drug MetabolismHomo sapiens
|
Creator: Selena Created On: September 14, 2023 at 23:02 Last Updated: September 14, 2023 at 23:02 |
PW146267 |
drug action
Barium sulfate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:49 Last Updated: October 07, 2023 at 17:49 |
PW146455 |
drug action
Baricitinib Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:14 Last Updated: October 07, 2023 at 18:14 |
PW132428 |
Baricitinib Drug MetabolismHomo sapiens
Baricitinib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Baricitinib passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 21:42 Last Updated: September 21, 2023 at 21:42 |
PW064796 |
bapHomo sapiens
|
Creator: Guest: Anonymous Created On: July 17, 2018 at 03:03 Last Updated: July 17, 2018 at 03:03 |
PW127628 |
drug action
Bamlanivimab Action PathwayHomo sapiens
Bamlanivimab, also known as LY-CoV555 or LY3819253, is a human IgG1K monoclonal antibody (mAb) against the SARS-CoV2 spike protein, called S. This drug was synthesized from the first blood samples of a patient who recovered from COVID-19 in the USA. This molecule is not approved by the FDA, but it is authorized under an Emergency Use Authorization (EUA) for the treatment of COVID-19 patients. X-ray crystallography and cryo-EM structural determination suggest that this molecule binds the receptor-binding domain (RBD) of the spike protein of CoV-19. This binding overlaps the ACE2 binding site. Bamlanivimab is available as an intravenous injection.
|
Creator: Daphnee Created On: May 16, 2023 at 13:02 Last Updated: May 16, 2023 at 13:02 |
PW063839 |
drug action
Bamipine H1-Antihistamine ActionHomo sapiens
Bamipine is a first-generation piperidine H1-antihistamine. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. Reducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors. Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. First-generation antihistamines readily cross the blood-brain barrier and cause sedation and other adverse central nervous system (CNS) effects (e.g. nervousness and insomnia). Second-generation antihistamines are more selective for H1-receptors of the peripheral nervous system (PNS) and do not cross the blood-brain barrier. Consequently, these newer drugs elicit fewer adverse drug reactions.
|
Creator: Carin Li Created On: September 24, 2017 at 21:35 Last Updated: September 24, 2017 at 21:35 |
PW145112 |
drug action
Balsalazide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:06 Last Updated: October 07, 2023 at 15:06 |